Bharat Parenterals Limited (BPLPHARMA.BO)
INR 987.9
(5.0%)
INR 987.9
(5.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.48 Billion INR | 264.58% |
| 2022 | 408.33 Million INR | 212.13% |
| 2021 | 130.82 Million INR | 33.17% |
| 2020 | 98.24 Million INR | 208.11% |
| 2019 | -90.86 Million INR | -24.8% |
| 2018 | -72.81 Million INR | -256.64% |
| 2017 | 46.48 Million INR | -3.69% |
| 2016 | 48.26 Million INR | -27.81% |
| 2015 | 66.85 Million INR | -55.4% |
| 2014 | 149.9 Million INR | -14.02% |
| 2013 | 174.34 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 901.9 Million INR | 0.0% |
| 2023 Q2 | 858 Million INR | 524.0% |
| 2023 Q1 | 137.5 Million INR | -66.33% |
| 2023 FY | 1.47 Billion INR | 261.6% |
| 2023 Q3 | 146.3 Million INR | -82.95% |
| 2023 Q4 | 1.48 Billion INR | 917.57% |
| 2022 Q4 | 408.33 Million INR | 101.05% |
| 2022 FY | 408.33 Million INR | 212.13% |
| 2022 Q3 | 203.1 Million INR | -44.08% |
| 2022 Q2 | 363.2 Million INR | 124.75% |
| 2022 Q1 | 161.6 Million INR | 23.53% |
| 2021 FY | 130.82 Million INR | 33.17% |
| 2021 Q2 | 92.3 Million INR | -79.59% |
| 2021 Q1 | 452.2 Million INR | 360.3% |
| 2021 Q4 | 130.82 Million INR | -59.72% |
| 2021 Q3 | 324.8 Million INR | 251.9% |
| 2020 Q1 | 104.1 Million INR | 218.25% |
| 2020 FY | 98.24 Million INR | 208.11% |
| 2020 Q4 | 98.24 Million INR | -4.62% |
| 2020 Q3 | 103 Million INR | 257.73% |
| 2020 Q2 | -65.3 Million INR | -162.73% |
| 2019 Q1 | 136.1 Million INR | 318.47% |
| 2019 Q3 | 187.19 Million INR | 822.78% |
| 2019 Q4 | -88.03 Million INR | -147.03% |
| 2019 Q2 | -25.9 Million INR | -119.03% |
| 2019 FY | -90.86 Million INR | -24.8% |
| 2018 Q4 | -62.29 Million INR | 0.0% |
| 2018 FY | -72.81 Million INR | -256.64% |
| 2017 Q4 | 51.74 Million INR | 0.0% |
| 2017 FY | 46.48 Million INR | -3.69% |
| 2017 Q1 | 15.83 Million INR | -67.19% |
| 2016 Q4 | 48.26 Million INR | 0.0% |
| 2016 FY | 48.26 Million INR | -27.81% |
| 2015 Q4 | 66.85 Million INR | 0.0% |
| 2015 FY | 66.85 Million INR | -55.4% |
| 2015 Q1 | 13.42 Million INR | 0.0% |
| 2014 FY | 149.9 Million INR | -14.02% |
| 2013 FY | 174.34 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| ANG Lifesciences India Limited | 671.01 Million INR | -121.859% |
| Add-Shop E-Retail Limited | 116.24 Million INR | -1180.629% |
| Bacil Pharma Limited | 569 Thousand INR | -261535.501% |
| Beryl Drugs Limited | 48.7 Million INR | -2956.389% |
| Cian Healthcare Limited | 544.97 Million INR | -173.171% |
| Colinz Laboratories Limited | -64.3 Million INR | 2415.142% |
| Concord Drugs Limited | 164.48 Million INR | -805.06% |
| Deccan Health Care Limited | -7.07 Million INR | 21138.807% |
| Gennex Laboratories Limited | -552.54 Million INR | 369.427% |
| Gujarat Terce Laboratories Limited | 37.76 Million INR | -3842.13% |
| Ishita Drugs and Industries Limited | -48.09 Million INR | 3195.152% |
| Kerala Ayurveda Limited | 447.82 Million INR | -232.428% |
| Kwality Pharmaceuticals Limited | 921.75 Million INR | -61.508% |
| Mercury Laboratories Limited | -26.72 Million INR | 5669.628% |
| Panchsheel Organics Limited | -157.82 Million INR | 1043.288% |
| Parmax Pharma Limited | 51.8 Million INR | -2773.4% |
| Parnax Lab Limited | 787.61 Million INR | -89.014% |
| Patidar Buildcon Limited | 25.12 Million INR | -5824.962% |
| Pharmaids Pharmaceuticals Limited | 37.28 Million INR | -3892.453% |
| Phaarmasia Limited | -4.89 Million INR | 30500.368% |
| Sandu Pharmaceuticals Limited | -11.43 Million INR | 13124.549% |
| Sastasundar Ventures Limited | -297.24 Million INR | 600.828% |
| SHELTER PHARMA LIMITED | -44.62 Million INR | 3436.111% |
| Source Natural Foods and Herbal Supplements Limited | -58.58 Million INR | 2641.061% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | -42.196% |
| Sunil Healthcare Limited | 625.4 Million INR | -138.039% |
| Syschem (India) Limited | 3.53 Million INR | -42049.094% |
| Trident Lifeline Limited | 117.56 Million INR | -1166.337% |
| Transchem Limited | -3.16 Million INR | 47166.266% |
| Tyche Industries Limited | -788.94 Million INR | 288.696% |
| Vikram Thermo (India) Limited | 38.62 Million INR | -3754.255% |
| Vasundhara Rasayans Limited | -76.15 Million INR | 2054.888% |
| Zenith Healthcare Limited | -25.45 Million INR | 5947.924% |
| Zenotech Laboratories Limited | -196.85 Million INR | 856.237% |
| Hindustan Bio Sciences Limited | 25.21 Million INR | -5804.437% |
| KIMIA BIOSCIENCES LIMITED | 431.72 Million INR | -244.826% |
| Chemo Pharma Laboratories Limited | -6.05 Million INR | 24674.216% |
| MedPlus Health Services Limited | 8.67 Billion INR | 82.847% |
| Sanjivani Paranteral Limited. | -85.95 Million INR | 1832.061% |
| Smruthi Organics Limited | 111.28 Million INR | -1237.694% |
| Trimurthi Limited | -1.17 Million INR | 126454.269% |
| Zenlabs Ethica Limited | 139.54 Million INR | -966.821% |
| Makers Laboratories Limited | 172.59 Million INR | -762.563% |
| Lactose (India) Limited | 373.97 Million INR | -298.081% |
| Bharat Immunologicals & Biologicals Corporation Limited | 689.39 Million INR | -115.945% |
| Roopa Industries Limited | 216.01 Million INR | -589.168% |
| PANJON LTD. | -12.8 Million INR | 11723.251% |
| TIAAN CONSUMER LIMITED | 13.44 Million INR | -10972.562% |
| Anuh Pharma Limited | -69.8 Million INR | 2232.603% |
| Crestchem Limited | -1.45 Million INR | 102769.379% |
| Emmessar Biotech & Nutrition Limited | -60.73 Million INR | 2551.271% |
| PRAVEG LIMITED | -434.98 Million INR | 442.241% |
| Fredun Pharmaceuticals Limited | 1.04 Billion INR | -42.596% |
| Shukra Pharmaceuticals Limited | -68.26 Million INR | 2280.775% |
| Norris Medicines Limited | 214.86 Million INR | -592.868% |
| Denis Chem Lab Limited | -236.28 Million INR | 730.047% |
| Veerhealth Care Limited | -2.38 Million INR | 62519.539% |
| Jenburkt Pharmaceuticals Limited | -791.91 Million INR | 287.988% |
| OXYGENTA PHARMACEUTICAL LIMITE | 571.32 Million INR | -160.569% |
| Godavari Drugs Limited | 530.02 Million INR | -180.877% |
| SHAMROCK INDUSTRIAL CO.LTD. | -9.31 Million INR | 16090.397% |
| Ambalal Sarabhai Enterprises Limited | 132.1 Million INR | -1026.954% |
| Vivanza Biosciences Limited | 50.02 Million INR | -2875.865% |
| Medi-Caps Limited | -3.21 Million INR | 46419.415% |
| DECIPHER LABS LIMITED | -93.13 Million INR | 1698.387% |
| Shree Ganesh Remedies Limited | 201.85 Million INR | -637.505% |
| Gujarat Themis Biosyn Limited | -53.88 Million INR | 2862.798% |
| BDH Industries Limited | -164.47 Million INR | 1005.154% |
| Vista Pharmaceuticals Limited | 78.7 Million INR | -1791.525% |
| Coral Laboratories Limited | -612.82 Million INR | 342.924% |
| Evoq Remedies Limited | 41.14 Million INR | -3517.93% |
| Trinity League India Limited | -12 Thousand INR | 12405983.333% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | -6.709% |
| Natural Capsules Limited | 956.68 Million INR | -55.612% |
| Auro Laboratories Limited | 252.51 Million INR | -489.549% |